CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $16,034,000 | +12.9% | 141,774 | -0.0% | 0.01% | 0.0% |
Q1 2017 | $14,198,000 | -6.9% | 141,787 | -0.1% | 0.01% | 0.0% |
Q4 2016 | $15,255,000 | -13.6% | 141,879 | +0.0% | 0.01% | -20.0% |
Q3 2016 | $17,659,000 | +81.4% | 141,863 | +55.0% | 0.01% | +66.7% |
Q2 2016 | $9,733,000 | +243225.0% | 91,549 | +326860.7% | 0.01% | – |
Q4 2015 | $4,000 | -76.5% | 28 | -88.8% | 0.00% | – |
Q4 2014 | $17,000 | +30.8% | 250 | 0.0% | 0.00% | – |
Q3 2014 | $13,000 | +225.0% | 250 | +150.0% | 0.00% | – |
Q2 2014 | $4,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |